A Study to Evaluate the Safety (Compared to Iron Sucrose), Efficacy and Pharmacokinetics of Ferumoxytol for the Treatment of Iron Deficiency Anemia (IDA) in Pediatric Subjects With Chronic Kidney Disease (CKD)
A phase 3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 129 participants.
Also called NCT03619850
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 129 participants
- Sponsor
- Registry
-
NCT03619850
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United States, Hungary, Lithuania, Mexico, Poland
- Registry status
- Recruiting
Technical summary
Registry record NCT03619850. Randomized; no masking; primary purpose treatment. Start 2018-08-13 (actual); primary completion 2026-08-31 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Study to Evaluate the Safety (Compared to Iron Sucrose), Efficacy and Pharmacokinetics of Ferumoxytol for the Treatment of Iron Deficiency Anemia (IDA) in Pediatric Subjects With Chronic Kidney Disease (CKD)
- Condition
- Chronic Kidney Disease; Iron Deficiency Anemia
- Intervention (Drug)
- Ferumoxytol
- Intervention (Drug)
- Iron sucrose
- Lead sponsor
- AMAG Pharmaceuticals, Inc.
Record details
- Record id
cardio:ct-nct03619850- Content hash
e92f0ba4a7aa3b274d97969e7d61f1c9011d45be066421095ec85a6afbf61805